ORCHESTRA

A Double-Blind, Placebo-Controlled, Randomized, 18-month Phase 2A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmakokinetics of oral UCB0599 in Study Participants with early-stage Parkinson's Disease.

For further information on the Orchestra Study, please visit orchestra-study.com.

Status: recruitment completed

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: